Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP854418.RAwbTIl44V9iTO7RGiElzK9OGNdmMNW_e0vPFrKiWKujw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP854418.RAwbTIl44V9iTO7RGiElzK9OGNdmMNW_e0vPFrKiWKujw130_assertion type Assertion NP854418.RAwbTIl44V9iTO7RGiElzK9OGNdmMNW_e0vPFrKiWKujw130_head.
- NP854418.RAwbTIl44V9iTO7RGiElzK9OGNdmMNW_e0vPFrKiWKujw130_assertion wasGeneratedBy ECO_0000203 NP854418.RAwbTIl44V9iTO7RGiElzK9OGNdmMNW_e0vPFrKiWKujw130_provenance.
- NP854418.RAwbTIl44V9iTO7RGiElzK9OGNdmMNW_e0vPFrKiWKujw130_assertion wasDerivedFrom befree-20150227 NP854418.RAwbTIl44V9iTO7RGiElzK9OGNdmMNW_e0vPFrKiWKujw130_provenance.
- NP854418.RAwbTIl44V9iTO7RGiElzK9OGNdmMNW_e0vPFrKiWKujw130_assertion SIO_000772 15148325 NP854418.RAwbTIl44V9iTO7RGiElzK9OGNdmMNW_e0vPFrKiWKujw130_provenance.
- NP854418.RAwbTIl44V9iTO7RGiElzK9OGNdmMNW_e0vPFrKiWKujw130_assertion evidence source_evidence_literature NP854418.RAwbTIl44V9iTO7RGiElzK9OGNdmMNW_e0vPFrKiWKujw130_provenance.
- NP854418.RAwbTIl44V9iTO7RGiElzK9OGNdmMNW_e0vPFrKiWKujw130_assertion description "[Oxysterols also inhibited protein kinase C activity and APP secretion following stimulation of protein kinase C. The selective expression of CYP46A1 around neuritic plaques and the potent inhibition of APP processing in neurons by 24(S)-hydroxycholesterol suggests that CYP46A1 affects the pathophysiology of AD and provides insight into how polymorphisms in the CYP46A1 gene might influence the pathophysiology of this prevalent disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP854418.RAwbTIl44V9iTO7RGiElzK9OGNdmMNW_e0vPFrKiWKujw130_provenance.